Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
US Army
Colorcon
Healthtrust
Mallinckrodt
Cerilliant
McKinsey
Medtronic
Johnson and Johnson
Harvard Business School

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203168

« Back to Dashboard

NDA 203168 describes PROLENSA, which is a drug marketed by Bausch And Lomb and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug and one Paragraph IV challenge. Additional details are available on the PROLENSA profile page.

The generic ingredient in PROLENSA is bromfenac sodium. Nine suppliers are listed for this compound. Additional details are available on the bromfenac sodium profile page.

Summary for 203168

Tradename:1
Applicant:1
Ingredient:1
Patents:8
Therapeutic Class:Ophthalmic Agents

Pharmacology for NDA: 203168

Suppliers and Packaging for NDA: 203168

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROLENSA bromfenac sodium SOLUTION/DROPS;OPHTHALMIC 203168 NDA Bausch & Lomb Incorporated 24208-602 24208-602-03 1 BOTTLE, DROPPER in 1 CARTON (24208-602-03) > 3 mL in 1 BOTTLE, DROPPER
PROLENSA bromfenac sodium SOLUTION/DROPS;OPHTHALMIC 203168 NDA Bausch & Lomb Incorporated 24208-602 24208-602-06 1 BOTTLE, DROPPER in 1 CARTON (24208-602-06) > .6 mL in 1 BOTTLE, DROPPER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrengthEQ 0.07% ACID
Approval Date:Apr 5, 2013TE:RLD:Yes
Patent:► SubscribePatent Expiration:Sep 11, 2025Product Flag?YSubstance Flag?YDelist Request?
Patent:► SubscribePatent Expiration:Jan 16, 2024Product Flag?YSubstance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Jan 16, 2024Product Flag?YSubstance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Queensland Health
Fuji
Accenture
Cantor Fitzgerald
Daiichi Sankyo
Covington
Novartis
Boehringer Ingelheim
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot